Changing the way we treat multiple myeloma based on biological markers in 2016
Ibrutinib in treatment for refractory or relapsed CLL
Upcoming clinical trials for venetoclax chemotherapy combinations for AML
What are the advantages of multiple myeloma maintenance therapy?
What is the best conditioning regimen for children